Sugi Predict

Sugi Predict / Compounds / SCHEMBL932701

SCHEMBL932701

SCHEMBL932701

CCCCCCCCCCCCCC(=O)CC(CC(=O)O)C(=O)CCCCCCCCCCCCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.55
▸ MAPT P10636 1/20 0.55
▸ GPR84 Q9NQS5 7/20 0.50
▸ PPARG P37231 7/20 0.50
▸ PPARD Q03181 7/20 0.50
▸ PPARA Q07869 7/20 0.50
▸ HDAC11 Q96DB2 5/20 0.50
▸ TSHR P16473 4/20 0.50
▸ PTPN1 P18031 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ TLR2 O60603 2/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ FABP4 P15090 2/20 0.50
▸ SLC22A6 Q4U2R8 1/20 0.50
▸ SLC22A8 Q8TCC7 1/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ ESR1 P03372 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ PDE4A P27815 1/20 0.50
▸ PDE3A Q14432 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL956434 0.91 PPARG (0.58) KMT2AMAPTPPARGPPARDPPARA
SCHEMBL956433 0.91 PPARG (0.58) KMT2AMAPTPPARGPPARDPPARA
SCHEMBL933570 0.86 KMT2A (0.56) KMT2AMAPTGPR84PPARGPPARD
SCHEMBL2999181 0.85 CES2 (0.52) KMT2AMAPTMEN1CES2
SCHEMBL933152 0.85 KMT2A (0.59) KMT2AMAPTGPR84PPARGPPARD
SCHEMBL1047282 0.85 KMT2A (0.59) KMT2AMAPTGPR84PPARGPPARD
SCHEMBL1047699 0.85 KMT2A (0.59) KMT2AMAPTGPR84PPARGPPARD
SCHEMBL9390983 0.84 CES2 (0.50) KMT2AMAPTMEN1CES2
SCHEMBL1259306 0.84 GPR84 (0.56) KMT2AGPR84PPARGPPARDPPARA
SCHEMBL1358131 0.84 GPR84 (0.56) KMT2AGPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11541010-B2 Amphoteric liposomes comprising imino lipids BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2023-01-03 — — US disclosed
US-20200330384-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2020-10-22 — — US disclosed
EP-2823810-B9 Amphoteric liposomes comprising imino lipids NOVOSOM VERWALTUNGS GMBH (DE) 2019-10-30 — — EP disclosed
EP-2823810-B1 Amphoteric liposomes comprising imino lipids NOVOSOM VERWALTUNGS GMBH (DE) 2019-03-27 — — EP disclosed
US-20180338919-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS NOVOSOM AG (DE) 2018-11-29 — — US disclosed
US-10039714-B2 Imino compounds for amphoteric liposomes and uses thereof NOVOSOM VERWALTUNGS GMBH (DE) 2018-08-07 — — US disclosed
EP-2451440-B2 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS MARINA BIOTECH INC (US) 2018-03-14 — — EP disclosed
US-20160338957-A1 IMINO COMPOUNDS FOR AMPHOTERIC LIPOSOMES AND USES THEREOF BIONTECH PROTEIN THERAPEUTICS GMBH (DE) 2016-11-24 — — US disclosed
EP-2823810-A1 Amphoteric liposomes comprising imino lipids Marina Biotech, Inc. (US) 2015-01-14 — — EP disclosed
EP-2451440-B1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS MARINA BIOTECH INC (US) 2014-11-12 — — EP disclosed
US-20140178462-A1 AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS MARINA BIOTECH, INC. (US) 2014-06-26 — — US disclosed
US-20120237589-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS MARINA BIOTECH, INC. (US) 2012-09-20 — — US disclosed
EP-2451440-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS Marina Biotech, Inc. (US) 2012-05-16 — — EP disclosed
EP-2277508-B1 Emulation of lipoprotein structures MARINA BIOTECH INC (US) 2012-04-25 — — EP disclosed
EP-2277508-A1 Emulation of lipoprotein structures Marina Biotech, Inc. (US) 2011-01-26 — — EP disclosed
WO-2011003834-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS MARINA BIOTECH, INC. (US) 2011-01-13 — — WO disclosed
US-20100330154-A1 AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS MARINA BIOTECH, INC. 2010-12-30 — — US disclosed
WO-2008155141-A2 NOVEL FACULTATIVE CATONIC STEROLS NOVOSOM AG (DE) 2008-12-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160338957-A1 IMINO COMPOUNDS FOR AMPHOTERIC LIPOSOMES AND USES THEREOF IPO8, IPO7, PHOSPHO1 KMT2A 2901/4885MAPT 4444/4885GPR84 2093/4885
US-11541010-B2 Amphoteric liposomes comprising imino lipids SGMS1, SGMS2, PHOSPHO1 KMT2A 3600/4885MAPT 4693/4885GPR84 1601/4885
US-20120237589-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS SGMS1, SGMS2, PHOSPHO1 KMT2A 3600/4885MAPT 4693/4885GPR84 1601/4885
US-10039714-B2 Imino compounds for amphoteric liposomes and uses thereof IPO8, IPO7, PHOSPHO1 KMT2A 2901/4885MAPT 4444/4885GPR84 2093/4885
US-20200330384-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS SGMS1, SGMS2, PHOSPHO1 KMT2A 3600/4885MAPT 4693/4885GPR84 1601/4885
US-20100330154-A1 AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS LIPA, CETP, SGMS1 KMT2A 866/4885MAPT 2723/4885GPR84 3380/4885
US-20180338919-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS SGMS1, SGMS2, PHOSPHO1 KMT2A 3600/4885MAPT 4693/4885GPR84 1601/4885
US-20140178462-A1 AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS LIPA, CETP, SGMS1 KMT2A 866/4885MAPT 2723/4885GPR84 3380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.